Revvity Rolls Out GSP T1D 3plex Kit

Revvity, Inc. (NYSE: RVTY) has launched the GSP® T1D 3plex kit, a fully automated and CE-IVDR-certified solution for multiplex autoantibody detection. This kit is designed to facilitate population-wide screening programs aimed at identifying children at risk of developing type 1 diabetes (T1D) prior to the onset of symptoms.